Skip to main content
Top
Published in: Supportive Care in Cancer 1/2012

01-01-2012 | Original Article

Pediatric patients with a malignant bone tumor: when does functional assessment make sense?

Authors: Corinna Caroline Winter, Carsten Müller, Jendrik Hardes, Joachim Boos, Georg Gosheger, Dieter Rosenbaum

Published in: Supportive Care in Cancer | Issue 1/2012

Login to get access

Abstract

Purpose

The diagnosis of a malignant bone tumor in the lower limb is a risk factor for physical disability, limiting physical performance. Walking ability especially, which is essential for most activities of daily living, is limited in those patients. In the present study, the extent of limitations during the course of treatment was investigated to determine when the assessment of functional parameters is meaningful in those patients.

Methods

In the present study, activity levels were determined in 20 patients with a malignant bone tumor in the lower limb who received endoprosthetic replacement of the affected bone and in 20 healthy individuals. A uniaxial accelerometer was used to investigate patients at five different time points after surgery.

Results

Patients performed significantly less amounts and intensities of activity than control individuals at all measurements. Significant increases in the volume of activity were observed after cessation of treatment. However, the intensity of activity only showed minor increases. Patients experiencing complications of surgery revealed greater restriction than those without even 18 months after surgery.

Conclusions

After cessation of treatment for their disease, patients recovered markedly and showed great improvements in physical activity. However, some limitations appeared to persist. Comparisons with patients with longer follow-up revealed that meaningful functional assessment does not make sense within the first 12 months after surgery. More research is needed to show if longer follow-up periods reveal further improvements. Based on such information, it should be more promising to develop individually tailored activity recommendations and intervention programs.
Literature
1.
go back to reference Demark-Wahnefried W, Werner C, Clipp EC et al (2005) Survivors of childhood cancer and their guardians. Cancer 103:2171–2180PubMedCrossRef Demark-Wahnefried W, Werner C, Clipp EC et al (2005) Survivors of childhood cancer and their guardians. Cancer 103:2171–2180PubMedCrossRef
2.
go back to reference Reeves M, Eakin E, Lawler S, Demark-Wahnefried W (2007) Health behaviours in survivors of childhood cancer. Aust Fam Physician 36:95–96PubMed Reeves M, Eakin E, Lawler S, Demark-Wahnefried W (2007) Health behaviours in survivors of childhood cancer. Aust Fam Physician 36:95–96PubMed
3.
go back to reference Florin TA, Fryer GE, Miyoshi T et al (2007) Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 16:1356–1363PubMedCrossRef Florin TA, Fryer GE, Miyoshi T et al (2007) Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 16:1356–1363PubMedCrossRef
4.
go back to reference Winter C, Muller C, Hoffmann C et al (2010) Physical activity and childhood cancer. Pediatr Blood Cancer 54:501–510PubMed Winter C, Muller C, Hoffmann C et al (2010) Physical activity and childhood cancer. Pediatr Blood Cancer 54:501–510PubMed
5.
go back to reference Ness KK, Hudson MM, Ginsberg JP et al (2009) Physical performance limitations in the childhood cancer survivor study cohort. J Clin Oncol 27:2382–2389PubMedCrossRef Ness KK, Hudson MM, Ginsberg JP et al (2009) Physical performance limitations in the childhood cancer survivor study cohort. J Clin Oncol 27:2382–2389PubMedCrossRef
6.
go back to reference Winter C, Muller C, Brandes M et al (2009) Level of activity in children undergoing cancer treatment. Pediatr Blood Cancer 53:438–443PubMedCrossRef Winter C, Muller C, Brandes M et al (2009) Level of activity in children undergoing cancer treatment. Pediatr Blood Cancer 53:438–443PubMedCrossRef
7.
go back to reference Dirksen U, Poremba C, Schuck A (2005) Knochentumoren des Kinder- und Jugendalters. Der Onkologe, 11:1034–1046 Dirksen U, Poremba C, Schuck A (2005) Knochentumoren des Kinder- und Jugendalters. Der Onkologe, 11:1034–1046
8.
go back to reference Sugiura H, Katagiri H, Yonekawa M et al (2001) Walking ability and activities of daily living after limb salvage operations for malignant bone and soft-tissue tumors of the lower limbs. Arch Orthop Trauma Surg 121:131–134PubMedCrossRef Sugiura H, Katagiri H, Yonekawa M et al (2001) Walking ability and activities of daily living after limb salvage operations for malignant bone and soft-tissue tumors of the lower limbs. Arch Orthop Trauma Surg 121:131–134PubMedCrossRef
9.
go back to reference Ness KK, Gurney JG (2007) Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health 28:279–302PubMedCrossRef Ness KK, Gurney JG (2007) Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health 28:279–302PubMedCrossRef
10.
go back to reference Geertzen JH, Bosmans JC, van der Schans CP, Dijkstra PU (2005) Claimed walking distance of lower limb amputees. Disabil Rehabil 27:101–104PubMedCrossRef Geertzen JH, Bosmans JC, van der Schans CP, Dijkstra PU (2005) Claimed walking distance of lower limb amputees. Disabil Rehabil 27:101–104PubMedCrossRef
11.
12.
go back to reference McDonald CM, Widman L, Abresch RT et al (2005) Utility of a step activity monitor for the measurement of daily ambulatory activity in children. Arch Phys Med Rehabil 86:793–801PubMedCrossRef McDonald CM, Widman L, Abresch RT et al (2005) Utility of a step activity monitor for the measurement of daily ambulatory activity in children. Arch Phys Med Rehabil 86:793–801PubMedCrossRef
13.
go back to reference Shepherd EF, Toloza E, McClung CD, Schmalzried TP (1999) Step activity monitor: increased accuracy in quantifying ambulatory activity. J Orthop Res 17:703–708PubMedCrossRef Shepherd EF, Toloza E, McClung CD, Schmalzried TP (1999) Step activity monitor: increased accuracy in quantifying ambulatory activity. J Orthop Res 17:703–708PubMedCrossRef
14.
go back to reference McDonald CM, Widman LM, Walsh DD et al (2005) Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 86:802–808PubMedCrossRef McDonald CM, Widman LM, Walsh DD et al (2005) Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 86:802–808PubMedCrossRef
15.
go back to reference Bjornson KF, Belza B, Kartin D et al (2007) Ambulatory physical activity performance in youth with cerebral palsy and youth who are developing typically. Phys Ther 87:248–257, discussion 257–260PubMedCrossRef Bjornson KF, Belza B, Kartin D et al (2007) Ambulatory physical activity performance in youth with cerebral palsy and youth who are developing typically. Phys Ther 87:248–257, discussion 257–260PubMedCrossRef
16.
go back to reference Rosenbaum D, Brandes M, Hardes J et al (2008) Physical activity levels after limb salvage surgery are not related to clinical scores—objective activity assessment in 22 patients after malignant bone tumor treatment with modular prostheses. J Surg Oncol 98:97–100PubMedCrossRef Rosenbaum D, Brandes M, Hardes J et al (2008) Physical activity levels after limb salvage surgery are not related to clinical scores—objective activity assessment in 22 patients after malignant bone tumor treatment with modular prostheses. J Surg Oncol 98:97–100PubMedCrossRef
17.
go back to reference Haskell WL, Lee IM, Pate RR et al (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1423–1434PubMedCrossRef Haskell WL, Lee IM, Pate RR et al (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1423–1434PubMedCrossRef
18.
go back to reference Tudor-Locke C, Hatano Y, Pangrazi RP, Kang M (2008) Revisiting “how many steps are enough?”. Med Sci Sports Exerc 40:S537–543PubMedCrossRef Tudor-Locke C, Hatano Y, Pangrazi RP, Kang M (2008) Revisiting “how many steps are enough?”. Med Sci Sports Exerc 40:S537–543PubMedCrossRef
19.
go back to reference Reinders-Messelink H, Schoemaker M, Snijders T et al (1999) Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 33:545–550PubMedCrossRef Reinders-Messelink H, Schoemaker M, Snijders T et al (1999) Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 33:545–550PubMedCrossRef
20.
go back to reference San Juan AF, Chamorro-Vina C, Mate-Munoz JL et al (2008) Functional capacity of children with leukemia. Int J Sports Med 29:163–167PubMedCrossRef San Juan AF, Chamorro-Vina C, Mate-Munoz JL et al (2008) Functional capacity of children with leukemia. Int J Sports Med 29:163–167PubMedCrossRef
21.
go back to reference Kawai A, Backus SI, Otis JC, Healey JH (1998) Interrelationships of clinical outcome, length of resection, and energy cost of walking after prosthetic knee replacement following resection of a malignant tumor of the distal aspect of the femur. J Bone Joint Surg Am 80:822–831PubMed Kawai A, Backus SI, Otis JC, Healey JH (1998) Interrelationships of clinical outcome, length of resection, and energy cost of walking after prosthetic knee replacement following resection of a malignant tumor of the distal aspect of the femur. J Bone Joint Surg Am 80:822–831PubMed
22.
go back to reference Kawai A, Backus SI, Otis JC et al (2000) Gait characteristics of patients after proximal femoral replacement for malignant bone tumour. J Bone Joint Surg Br 82:666–669PubMedCrossRef Kawai A, Backus SI, Otis JC et al (2000) Gait characteristics of patients after proximal femoral replacement for malignant bone tumour. J Bone Joint Surg Br 82:666–669PubMedCrossRef
23.
go back to reference Gebert C, Hardes J, Hoffmann C et al (2002) Options for surgical treatment of malignant bone tumors. Chirurg 73:1162–1169PubMedCrossRef Gebert C, Hardes J, Hoffmann C et al (2002) Options for surgical treatment of malignant bone tumors. Chirurg 73:1162–1169PubMedCrossRef
24.
go back to reference Mittermayer F, Krepler P, Dominkus M et al (2001) Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res 388:167–177PubMedCrossRef Mittermayer F, Krepler P, Dominkus M et al (2001) Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res 388:167–177PubMedCrossRef
25.
go back to reference Gosheger G, Gebert C, Ahrens H et al (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–171PubMedCrossRef Gosheger G, Gebert C, Ahrens H et al (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–171PubMedCrossRef
Metadata
Title
Pediatric patients with a malignant bone tumor: when does functional assessment make sense?
Authors
Corinna Caroline Winter
Carsten Müller
Jendrik Hardes
Joachim Boos
Georg Gosheger
Dieter Rosenbaum
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 1/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-1077-5

Other articles of this Issue 1/2012

Supportive Care in Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine